{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9UNA3",
      "entity_text" : "alpha4GnT",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0400" ],
      "Organ" : [ "uberon:UBERON:0000105" ]
    }
  },
  "verbose_text" : "Shimizu et al confirmed that alpha4GnT, which forms a unique glycan, GlcNAcalpha1--> 4Galbeta--> R, is detectable in 80% of 5 patients with an early stage of gastric cancer and the expression level of alpha4GnT mRNA is increased in association with tumor progression.",
  "reading_complete" : "2020-08-02T13:58:08Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:56:54Z",
  "trigger" : "level",
  "evidence" : [ "level\nof alpha4GnT" ],
  "pmc_id" : "4042861",
  "score" : 0
}